{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:43:02Z","timestamp":1790037782807,"version":"4.0.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2000,4,28]],"date-time":"2000-04-28T00:00:00Z","timestamp":956880000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2000,4,28]],"date-time":"2000-04-28T00:00:00Z","timestamp":956880000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2000,5,1]]},"DOI":"10.1038\/sj.leu.2401779","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T18:34:33Z","timestamp":1031164473000},"page":"853-858","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Immunotoxins against CD19 and CD22 are effective in killing precursor-B acute lymphoblastic leukemia cells in vitro"],"prefix":"10.1038","volume":"14","author":[{"given":"L","family":"Herrera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RA","family":"Farah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"VA","family":"Pellegrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DB","family":"Aquino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ES","family":"Sandler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GR","family":"Buchanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ES","family":"Vitetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2000,4,28]]},"reference":[{"key":"BF2401779_CR1","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/00001622-199701000-00005","volume":"9","author":"LB Silverman","year":"1997","unstructured":"Silverman LB, Weinstein HJ . Treatment of childhood leukemia Curr Opin Oncol 1997 9: 26\u201333","journal-title":"Curr Opin Oncol"},{"key":"BF2401779_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/0163-7258(94)90025-6","volume":"63","author":"V Ghetie","year":"1994","unstructured":"Ghetie V, Vitetta ES . Immunotoxins in the therapy of cancer: from bench to clinic Pharm Ther 1994 63: 209\u2013234","journal-title":"Pharm Ther"},{"key":"BF2401779_CR3","first-page":"27","volume":"1198","author":"I Pastan","year":"1994","unstructured":"Pastan I, Brinkmann U . Immunotoxins against cancer Biochim Biophys Acta 1994 1198: 27\u201345","journal-title":"Biochim Biophys Acta"},{"key":"BF2401779_CR4","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1182\/blood.V85.12.3457.bloodjournal85123457","volume":"85","author":"EA Sausville","year":"1995","unstructured":"Sausville EA, Headlee D, Stetler-Stevenson M, Jaffe ES, Solomon D, Figg WD, Herdt J, Kopp WC, Rager H, Steinberg SM, Ghetie V, Schindler J, Uhr J, Wittes RE, Vitetta ES . Continuous infusion of the anti-CD22 immunotoxin IgG-RFB4-SMPT-dgA in patients with B-cell lymphoma: a phase I study Blood 1995 85: 3457\u20133465","journal-title":"Blood"},{"key":"BF2401779_CR5","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1182\/blood.V82.9.2624.2624","volume":"82","author":"PL Amlot","year":"1993","unstructured":"Amlot PL, Stone MJ, Cunningham D, Fay J, Newman J, Collins R, May R, McCarthy M, Richardson J, Ghetie V, Ramilo O, Thorpe PE, Uhr JW, Vitetta ES . A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy Blood 1993 82: 2624\u20132633","journal-title":"Blood"},{"key":"BF2401779_CR6","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/00002371-199304000-00007","volume":"13","author":"K Selvaggi","year":"1993","unstructured":"Selvaggi K, Saria EA, Schwartz R, Vlock DR, Ackerman S, Wedel N, Kirkwood JM, Jones H, Ernstoff MS . Phase I\/II study of murine monoclonal antibody-ricin A chain (XOMAZYME-MeI) immunoconjugate plus cyclosporine A in patients with metastatic melanoma J Immunother 1993 13: 201\u2013207","journal-title":"J Immunother"},{"key":"BF2401779_CR7","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3109\/10428199409049633","volume":"13","author":"A Engert","year":"1994","unstructured":"Engert A, Gottstein C, Winkler U, Amlot P, Pileri S, Diehl V, Thorpe P . Experimental treatment of human Hodgkin's disease with ricin A-chain immunotoxins Leuk Lymphoma 1994 13: 441\u2013448","journal-title":"Leuk Lymphoma"},{"key":"BF2401779_CR8","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1182\/blood.V78.5.1173.1173","volume":"78","author":"CF LeMaistre","year":"1991","unstructured":"LeMaistre CF, Rosen S, Frankel A, Kornfeld S, Saria E, Meneghetti C, Drajesk J, Fishwild D, Scannon P, Byers V . Phase I trial of H65-RTA immunoconjugate in patients with cutaneous T-cell lymphoma Blood 1991 78: 1173\u20131182","journal-title":"Blood"},{"key":"BF2401779_CR9","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/0140-6736(92)91135-U","volume":"339","author":"B Falini","year":"1992","unstructured":"Falini B, Bolognesi A, Flenghi L, Tazzari PL, Broe MK, Stein H, Durkop H, Aversa F, Corneli P, Pizzolo G, Barbabietola G, Sabattini E, Pileri S, Martelli MF, Stirpe F . Response of refractory Hodgkin's disease to monoclonal anti-CD30 immunotoxin Lancet 1992 339: 1195\u20131196","journal-title":"Lancet"},{"key":"BF2401779_CR10","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/00002371-199511000-00004","volume":"18","author":"RM Conry","year":"1995","unstructured":"Conry RM, Khazaeli MB, Saleh MN, Ghetie V, Vitetta ES, Liu T, Lobuglio AF . Phase I trial of an anti-CD19 deglycosylated ricin A chain immunotoxin in non-Hodgkin's lymphoma: effect of an intensive schedule of administration J Immunother 1995 18: 231\u2013241","journal-title":"J Immunother"},{"key":"BF2401779_CR11","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1182\/blood.V88.4.1188.bloodjournal8841188","volume":"88","author":"MJ Stone","year":"1996","unstructured":"Stone MJ, Sausville EA, Fay JW, Headlee D, Collins RH, Figg WD, Stetler-Stevenson M, Jain V, Jaffe ES, Solomon D, Lush RM, Senderowicz A, Ghetie V, Schindler J, Uhr JW, Vitetta ES . A phase I study of bolus vs continuous infusion of the anti-CD19 immunotoxin, IgG-HD37-dgA in patients with B cell lymphoma Blood 1996 88: 1188\u20131197","journal-title":"Blood"},{"key":"BF2401779_CR12","unstructured":"Current Clinical Trials, Oncology. (Book on CD-ROM) Green Brook: New Jersey 1999"},{"key":"BF2401779_CR13","first-page":"2610","volume":"48","author":"M Ghetie","year":"1988","unstructured":"Ghetie M, May RD, Till M, Uhr JW, Ghetie V, Knowles PP, Relf M, Brown A, Wallace PM, Janossy G, Amlot P, Vitetta ES, Thorpe PE . Evaluation of ricin A chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B-cells as potential reagents for in vivo therapy Cancer Res 1988 48: 2610\u20132617","journal-title":"Cancer Res"},{"key":"BF2401779_CR14","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1089\/cdd.1986.3.261","volume":"3","author":"RD May","year":"1986","unstructured":"May RD, Vitetta ES, Moldenhauer G, Dorken B . Selective killing of normal and neoplastic human B cells with anti-CD19 and anti-CD22 ricin a chain immunotoxins Cancer Drug Del 1986 3: 261\u2013270","journal-title":"Cancer Drug Del"},{"key":"BF2401779_CR15","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1002\/ijc.2910420527","volume":"42","author":"G Shen","year":"1988","unstructured":"Shen G, Li J, Ghetie M, Ghetie V, May RD, Till M, Brown AN, Relf M, Knowles P, Uhr JW, Janossy G, Amlot P, Vitetta ES, Thorpe PE . Evaluation of four CD22 antibodies as ricin A chain-containing immunotoxins for the in vivo therapy of human B cell leukemias and lymphomas Int J Cancer 1988 42: 792\u2013797","journal-title":"Int J Cancer"},{"key":"BF2401779_CR16","first-page":"5876","volume":"51","author":"M Ghetie","year":"1991","unstructured":"Ghetie M, Richardson J, Tucker T, Jones D, Uhr JW, Vitetta ES . Antitumor activity of Fab\u2032 and IgG-anti-CD22 immunotoxins in disseminated human B lymphoma grown in mice with severe combined immunodeficiency disease: effect on tumor cells in extranodal sites Cancer Res 1991 51: 5876\u20135880","journal-title":"Cancer Res"},{"key":"BF2401779_CR17","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1182\/blood.V80.9.2315.2315","volume":"80","author":"M Ghetie","year":"1992","unstructured":"Ghetie M, Tucker K, Richardson J, Uhr JW, Vitetta ES . The antitumor activity of an anti-CD22 immunotoxin in SCID mice with disseminated Daudi lymphoma is enhanced by either an anti-CD19 antibody or an anti-CD19 immunotoxin Blood 1992 80: 2315\u20132320","journal-title":"Blood"},{"key":"BF2401779_CR18","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/(SICI)1097-0215(19960927)68:1<93::AID-IJC16>3.0.CO;2-7","volume":"68","author":"M Ghetie","year":"1996","unstructured":"Ghetie M, Podar EM, Gordon BE, Pantazis P, Vitetta ES . Combination immunotoxin treatment and chemotherapy in SCID mice with advanced, disseminated Daudi lymphoma Int J Cancer 1996 68: 93\u201396","journal-title":"Int J Cancer"},{"key":"BF2401779_CR19","first-page":"4052","volume":"51","author":"ES Vitetta","year":"1991","unstructured":"Vitetta ES, Stone M, Amlot P, Fay J, May R, Till M, Uhr JW, Thorpe PE . Phase I immunotoxin trial in patients with B cell lymphoma Cancer Res 1991 51: 4052\u20134058","journal-title":"Cancer Res"},{"key":"BF2401779_CR20","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/ijc.2910230206","volume":"23","author":"R Hurwitz","year":"1979","unstructured":"Hurwitz R, Hozier J, LeBien T, Minowada J, Gaji-Peczalska K, Kubonishi I, Kersey J . Characterization of a leukemic cell line of the pre-B phenotype Int J Cancer 1979 23: 174\u2013180","journal-title":"Int J Cancer"},{"key":"BF2401779_CR21","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3109\/10428199409049624","volume":"13","author":"D Campana","year":"1994","unstructured":"Campana D, Coustan-Smith E, Kumagai M, Manabe A . Growth requirements of normal and leukemic human B cell progenitors Leuk Lymphoma 1994 13: 359\u2013371","journal-title":"Leuk Lymphoma"},{"key":"BF2401779_CR22","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1146\/annurev.iy.07.040189.000551","volume":"7","author":"PW Kincade","year":"1989","unstructured":"Kincade PW, Lee G, Pietrangeli CE, Hayashi SI, Gimble JM . Cells and molecules that regulate B lymphopoiesis in bone marrow Ann Rev Immunol 1989 7: 111\u2013143","journal-title":"Ann Rev Immunol"},{"key":"BF2401779_CR23","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1182\/blood.V84.3.702.702","volume":"84","author":"M Ghetie","year":"1994","unstructured":"Ghetie M, Tucker K, Richardson J, Uhr JW, Vitetta ES . Eradication of minimal disease in severe combined immunodeficient mice with disseminated daudi lymphoma using chemotherapy and an immunotoxin cocktail Blood 1994 84: 702\u2013707","journal-title":"Blood"},{"key":"BF2401779_CR24","doi-asserted-by":"crossref","unstructured":"Nadler LM, Reinherz EL, Haynes BF, Nadler LM, Bernstein ID (eds) . Leukocyte Typing II. B-cell\/leukemia panel workshop: summary and comments Springer-Verlag: New York 1986 p 3","DOI":"10.1007\/978-1-4612-4848-4_1"},{"key":"BF2401779_CR25","unstructured":"Sato S, Teddler TF, Kishimoto T, Kukutani H et al (eds). BC3, CD19 Workshop Panel report. Leukocyte Typing VI. White Cell Differentiation Antigens, 6th edn Garland Publishing: New York 1999 pp 133\u2013134"},{"key":"BF2401779_CR26","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3109\/10428199509059636","volume":"18","author":"RH Scheuermann","year":"1995","unstructured":"Scheuermann RH, Racila E . CD19 antigen in leukemia and lymphoma diagnosis and immunotherapy Leuk Lymphoma 1995 18: 385\u2013397","journal-title":"Leuk Lymphoma"},{"key":"BF2401779_CR27","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1084\/jem.163.2.347","volume":"163","author":"FM Uckun","year":"1986","unstructured":"Uckun FM, Gaji-Peczalska KJ, Kersey JH, Houston LL, Vallera DA . Use of a novel colony assay to evaluate the cytotoxicity of an immunotoxin containing pokeweed antiviral protein against blast progenitor cells freshly obtained from patients with common B-lineage acute lymphoblastic leukemia J Exp Med 1986 163: 347\u2013368","journal-title":"J Exp Med"},{"key":"BF2401779_CR28","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/ijc.2910620318","volume":"62","author":"DJ Flavell","year":"1995","unstructured":"Flavell DJ, Boehm DA, Emery L, Noss A, Ramsay A, Flavell SU . Therapy of human B-cell lymphoma bearing SCID mice is more effective with anti-CD19-and anti-CD38-saporin immunotoxins used in combination than with either immunotoxin used alone Int J Cancer 1995 62: 337\u2013344","journal-title":"Int J Cancer"},{"key":"BF2401779_CR29","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1182\/blood.V79.9.2370.2370","volume":"79","author":"A Manabe","year":"1992","unstructured":"Manabe A, Coustan-Smith E, Behm FG, Raimondi SC, Campana D . Bone marrow-derived stromal cells prevent apoptotic cell death in B-lineage acute lymphoblastic leukemia Blood 1992 79: 2370\u20132377","journal-title":"Blood"},{"key":"BF2401779_CR30","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1093\/jnci\/81.8.570","volume":"81","author":"RK Jain","year":"1989","unstructured":"Jain RK . Delivery of novel therapeutic agents in tumors: physiological barriers and strategies J Natl Cancer Inst 1989 81: 570\u2013576","journal-title":"J Natl Cancer Inst"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2401779.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2401779","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2401779.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T20:09:32Z","timestamp":1648757372000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2401779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,4,28]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2000,5,1]]}},"alternative-id":["BF2401779"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2401779","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,4,28]]},"assertion":[{"value":"18 November 1999","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2000","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2000","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}